logo
Select company
Select metric
$ 24.17MNet Income Common Stock
VS
Market
58
Sector
85
Industry
94
History
100
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information

Ticker

GLUE

Company Name

MONTE ROSA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MONTE ROSA THERAPEUTICS INC - Net Income Common Stock Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GLUE - Net Inc. Cmn. Historical data
DateNet Income Common Stock
6/30/2025$ 24.17M
3/31/2025$ 6.15M
12/31/2024$ -72.7M
9/30/2024$ -119.39M
6/30/2024$ -130.41M
3/31/2024$ -135.28M
12/31/2023$ -135.35M
9/30/2023$ -132.88M
6/30/2023$ -125.32M
3/31/2023$ -116.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) Net Inc. Cmn. stands at $ -35.88M.
  • Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average Net Inc. Cmn. has been $ -89.78M.
  • The median Net Inc. Cmn. for MONTE ROSA THERAPEUTICS INC during this period was $ -104.83M
  • MONTE ROSA THERAPEUTICS INC reached its highest Net Inc. Cmn. over the past 5 years at $ 24.17M.
  • The lowest Net Inc. Cmn. recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe $ -135.35M

MONTE ROSA THERAPEUTICS INC's Net Inc. Cmn. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. Cmn. Benchmarks
CompanyNet Inc. Cmn.
VNDA : VANDA PHARMACEUTICALS INC $ -66.94MHRTX : HERON THERAPEUTICS INC $ -931KARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -60.16MCTMX : CYTOMX THERAPEUTICS INC $ 47.98MRGNX : REGENXBIO INC $ -175.57MMGNX : MACROGENICS INC $ -36.4MTRDA : ENTRADA THERAPEUTICS INC $ -73.35MPBYI : PUMA BIOTECHNOLOGY INC $ 48.45MCDXS : CODEXIS INC $ -64.98MSCPH : SCPHARMACEUTICALS INC $ -91.72M

Definition of Net Income Common Stock

[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].

GLUE - Net Income Common Stock, Last 5 years

$ -135.35M

Minimum

Dec 31, 2023

$ 24.17M

Maximum

Jun 30, 2025

$ -89.78M

Average

$ -104.83M

Median

Net Inc. Cmn. Benchmark Analysis

The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 9.27M with a standard deviation of $ 113.61M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
filtered constituents3.37K
min$ -354.46M
max$ 366.43M
average$ 9.27M
median$ -2.46M
std$ 113.61M